Evofem Biosciences (EVFM) Proxy Filing summary

Executive summary

• Special Meeting of Stockholders rescheduled to October 20, 2025, at 9:00 am Pacific Time.

• All proposals to be presented at the meeting remain unchanged from the previous proxy statement.

Voting matters and shareholder proposals

• Proposals to be considered and voted upon at the Special Meeting are unchanged from those previously disclosed.

Shareholder rights and capital structure

• Dissenters' (appraisal) rights are available for the proposals, as per Delaware General Corporation Law Section 262.

• Stockholders must follow specific procedures, including written demand for appraisal before the vote, to exercise appraisal rights.

• Failure to comply with Section 262 procedures results in loss of appraisal rights; legal and financial consultation is advised.

• Stockholders who do not exercise appraisal rights will receive the Merger Consideration.